|
|
Pharmaceutical Regulatory Affairs 2011 will focus on implementing and enhancing pharmaceutical compliance and quality procedures to access pharma markets in Asia. It will bring together regulators and pharma executive to discuss about future laws on regulatory affairs and current initiatives and also convey timely information. This conference will provide a wonderful platform for the participants to gain knowledge and share experience with the renowned pharma companies, who have adopted regulatory strategy into their business. The event will also include presentations and interactive discussions on a number of topics, like drug registration, intellectual property, labeling & packaging, pricing & reimbursement, patent protection, harmonization of standards and licensing.
The conference will cover the topics mentioned below:
- Pharmacovigilance: compliance with regulatory requirements
- Drug regulatory system: safeguarding public health
- Regulatory updates on marketing high-value specialist products in Asia
- Regulatory trends in Asia
- Strengthening regional regulatory frameworks through partnership: review of Asean harmonisation inititiaves
- Regulatory regimes on innovations in pharma
- Compliance and quality risk management
- Understanding new drug registration regulations in the Philippines
- An update on the biopharma industry in Hong Kong: perspectives from a globally-focused, Asian-based, life sciences company
- Drug regulatory harmonization initiatives & trends throughout Asia
- Drug regulatory asia review of 2009: current environment for regulatory authorities and industry
- Regulations for medical devices in Asia pacific
- Understanding the law principles affecting patents, data exclusivity and other rights relating to manufacture and sales
- understanding pharmaceutical regulations and policies on advertising and marketing of prescription drugs in Singapore
- Challenges in establishing quality assurance system in biopharmaceuticals
- Regulations for clinical trials & product registration in India
- Product registration: easy and cost-effectiveness measures to get medical product registered
- Understanding and maximising the regulatory procedures of the drug supply chain in Asia
- Developments and updates on the pharmaceutical regulatory systems in China, Hong Kong and Taiwan
Visitor Profile
The targeted visitors at the Pharmaceutical Regulatory Affairs 2011 would include GM, Senior Managers, Partners, Executive Directors, Senior Executives, CEOs and Heads from:
- Pharmaceutical Manufacturers
- Life Sciences
- Medical Devices
- Pharmaceutical Distributors
- Clinical research
- CRO
- CMO
- Biotech
Organizer
The Asia Business Forum
